Glenn Goddard
Director of Finance/CFO at INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Currently, Glenn Goddard occupies the position of Executive VP, Chief Financial & Accounting Officer at Intellia Therapeutics, Inc. He previously occupied the position of Senior Vice President-Finance of Agios Pharmaceuticals, Inc., Chief Financial Officer for Generation Bio Co., Controller at ImmunoGen, Inc., Vice President-Finance of Archemix Corp., Principal at Ernst & Young LLP and Principal at Feeley & Driscoll PC. Glenn Goddard received an undergraduate degree from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 69,213 ( 0.07% ) | 2 M $ | 2024-03-30 |
Glenn Goddard active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Director of Finance/CFO | 2018-10-28 |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | - |
Former positions of Glenn Goddard
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2016-09-18 |
| GENERATION BIO CO. | Director of Finance/CFO | - |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Comptroller/Controller/Auditor | - |
Training of Glenn Goddard
| Bentley University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| GENERATION BIO CO. | Health Technology |
| Private companies | 3 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Glenn Goddard
